CANNABICHROMENE AS A THERAPEUTIC MODALITY FOR COVID-19
Application
US20260097051A1
Kind: A1
Apr 09, 2026
Assignee
AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
Inventors
Babak BABAN, Krishnan DHANDAPANI, Jack YU
Abstract
Compositions and methods for treating or reducing symptoms of acute respiratory distress syndrome (ARDS) generally and COVID-19 infection, in particular, are provided. An exemplary method includes administering to the subject an effective amount of cannabichromene to reduce acute respiratory distress caused by ARDS generally and COVID-19 infection, in particular.
CPC Classifications
A61K 31/658
A61K 9/0073
A61P 29/00
A61P 31/14
Filing Date
2025-08-18
Application No.
19303075